Table 1.
Baseline Characteristics of HIV-Infected Adults at Enrollment (N = 40 408).
| Characteristics | N (%) |
|---|---|
| Gender | |
| Female | 26 920 (66) |
| Age group, years | |
| Median (minimum–maximum) | 37 (15–98) |
| <30 | 8922 (22) |
| 30≤40 | 17 460 (44) |
| 40≤50 | 9523 (24) |
| ≥50 | 4074 (10) |
| BMI group, kg/m2 | |
| <18.5 | 10 953 (29) |
| 18.5≤25 | 20 418 (53) |
| 25.0≤30 | 4925 (13) |
| ≥30 | 1947 (5) |
| WHO stage | |
| I | 5407 (14) |
| II | 7136 (18) |
| III | 17 522 (45) |
| IV | 8693 (22) |
| CD4 count, cells/mm3 | |
| <50 | 8045 (21) |
| 50≤200 | 13 259 (35) |
| ≥200 | 16 514 (44) |
| Others | |
| Previous ARV medication use | 4046 (10) |
| On TB treatment | 3654 (10) |
| Oral candidiasis | 2981 (8) |
| Chronic diarrhea | 2457 (7) |
| Wasting | 6628 (18) |
| Serum creatinine >1.2 mmol/L | 4013 (16) |
| Kaposi’s sarcoma | 291 (0.7) |
| On cotrimoxazole prophylaxis | 3636 (11) |
| Anemia categories | |
| Median(minimun–maximum) | 10.4 (1.1–42.9) |
| Hb <11 g/dL | 23 842 (59.0) |
| Hb <8.5 g/dL | 8894 (22.0) |
| Microcytica and Hgb <8.5 g/dL | 5937 (15.4) |
| Macrocyticb and Hgb <8.5 g/dL | 109 (0.3) |
| Normocyticc and Hgb <8.5 g/dL | 2476 (6.4) |
Abbreviation: Hgb, hemoglobin; ARV, antiretroviral; BMI, body mass index; MCV, mean corpuscular volume; TB, tuberculaosis; WHO, World Health Organization.
a
Microcytic defined as MCV < 80.
b
Macrocytic defined as MCV > 100.
c
Normocytic defined as MCV = 80–100.